Animal Blood Plasma Products and Derivatives Market | 2031
Animal Blood Plasma Products and Derivatives Market | 2031
Segments - Animal Blood Plasma Products and Derivatives Market by Animal Type (Ovine and Bovine), Derivatives Type (Serum Albumin, Fetal Bovine Serum, Immunoglobulin, Fibrinogen, and Others), Application (Cosmetic, Diagnostic, Pet Food, Cell Culture Media, Food, Pharmaceutical, Sports Nutrition, and Nutrition Supplements), and Region (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 – 2031
Upcoming
| Report ID :HC-5142
| 4.7 Rating
| 77 Reviews
| 211 Pages
| Format :
Report Description
The global animal blood plasma products and derivatives market size was USD 1.08 Bn in 2022 and is likely to reach USD 1.94 Bn by 2031, expanding at a CAGR of 7.12% during 2023–2031. Rising application of animal blood plasma products and derivatives in the food industry is anticipated to drive the market during the forecast period.
Animal blood plasma products and derivatives are derived from the blood of several species including pigs, cattle, and sheep. These products and derivatives have a wide range of applications in the pharmaceutical, agriculture, and medical industries. Some animal blood plasma derivatives include albumin, which is a protein. This protein regulates blood pressure and volume and is used to treat conditions such as burns and shock.
Immunoglobulins are a type of blood plasma protein that is used to treat immune disorders and infections. Clotting factors are proteins that aid in a blood clot. It is derived from animal blood plasma and used to treat the bleeding disorder. The use of animal-derived products is highly regulated, and strict safety protocols are in place to ensure that they are free from pathogens and contaminants.
The research report finds that the COVID-19 pandemic propelled the animal blood plasma products and derivatives market to a significant extent. The market has not faced maximum hurdles during the pandemic, as all the activities related to food products were operational. However, there is some controversy surrounding the use of animal blood products, generally in the context of animal welfare concerns. The potential risk of transmitting diseases from animals to humans is high. Thus, researchers are concentrating on alternate sources including synthetic materials and recombinant technologies.
Animal Blood Plasma Products and Derivatives Market Dynamics
Major Drivers
Advancements in the blood collection processes are projected to drive the market during the forecast period. Plasma products and derivatives have great demand from several industries including the pharmaceutical industry, nutrition supplements, sports nutrition, cosmetic industry, and diagnostics. Key players are concentrating on the supply chain, which leads to the easy availability of products.
Existing Restraints
Increasing prevalence of diseases among animals is anticipated to hinder the market in the coming years. Furthermore, the price of animal blood plasma products keeps changing and is expected to restrain the market expansion.
Emerging Opportunities
Research & development activities to improve the techniques for processing blood plasma and derivatives are expected to create lucrative opportunities for market players. Researchers found a suitable alternative for the plant-extracted proteins which are animal blood plasma products and derivatives for manufacturing pet food.
Scope of the Animal Blood Plasma Products and Derivatives Market Report
The market report includes an assessment of the market trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes |
Details |
|
Report Title |
Animal Blood Plasma Products and Derivatives Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
|
Base Year |
2022 |
|
Historic Data |
2016–2021 |
|
Forecast Period |
2023–2031 |
|
Segmentation |
Animal Type (Ovine and Bovine), Derivatives Type (Serum Albumin, Fetal Bovine Serum, Immunoglobulin, Fibrinogen, and Others), and Application (Cosmetic, Diagnostic, Pet Food, Cell Culture Media, Food, Pharmaceutical, Sports Nutrition, and Nutrition Supplements) |
|
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
|
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Market Trends, and Revenue Forecast |
|
Key Players Covered in the Report |
Kedrion Biopharma, Inc.; LFB S.A; Octapharma AG; Takeda; Sanofi; Grifols; Bayer AG; Biotest AG; CSL Limited; and Fusion Health Care Pvt. Ltd |
Animal Blood Plasma Products and Derivatives Market Segment Insights
On the basis of animal type, the animal blood plasma products and derivatives market is bifurcated into ovine and bovine. The ovine segment is projected to expand at a considerable CAGR during the forecast period. An animal from the genus Ovis is a sheep. Sonac ovine plasma powder is produced from the ovine blood of free-range sheep and lambs found in Australia. It is used to formulate limited-ingredient treats, wet pet food, and snacks. The bovine segment is anticipated to account for a major market share during the forecast period. Bovine plasma product has application in the treatment of failure of passive transfer in calves.
Based on derivatives type, the market is divided into serum albumin, fetal bovine serum, immunoglobulin, fibrinogen, and others. The serum albumin segment is expected to hold a significant share of the market in the coming years. Serum albumin is used in various clinical conditions. Clinical applications of albumin include acute management of burns, restoration of blood volume, and other situations associated with hypovolemia. The fetal bovine serum segment accounts for a significant market share. Fetal bovine serum is utilized as a growth supplement for the in vitro cell culture.
On the basis of application, the market is segregated into cosmetic, diagnostic, pet food, cell culture media, food, pharmaceutical, sports nutrition, and nutrition supplements. The diagnostic segment is anticipated to expand at a substantial CAGR during the forecast period. Plasma protein test is being carried out to detect the total protein in the blood. This test helps physicians to determine patient’s overall health. The pharmaceutical segment is expected to hold a significant share of the market. Animal blood plasma has various applications in the pharmaceutical industry. For instance, doctors recommend plasma powder to improve gut health and feed palatability.
In terms of region, the global animal blood plasma products and derivatives market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is expected to dominate the market during the forecast period, owing to the rising usage of animal blood plasma products and derivatives in different applications including the pet food industry and sports nutrition.
Availability of advanced technologies for blood fractionation is projected to propel the market in the region. In New Zealand and Australia, the import of live cattle animals is increased, then they are utilized for the production of plasma products and derivatives. Major players in the region focus on the diversity of various cell lines and their cellular interactions. The rapid expansion of the market in Asia Pacific is attributed to the presence of prominent market players in the region.
Segments
The global animal blood plasma products and derivatives market has been segmented on the basis of
Animal Type
- Ovine
- Bovine
Derivatives Type
- Serum Albumin
- Fetal Bovine Serum
- Immunoglobulin
- Fibrinogen
- Others
Application
- Cosmetic
- Diagnostic
- Pet Food
- Cell Culture Media
- Food
- Pharmaceutical
- Sports Nutrition
- Nutrition Supplements
Region
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
- Kedrion Biopharma, Inc.
- LFB S.A
- Octapharma AG
- Takeda
- Sanofi
- Grifols
- Bayer AG
- Biotest AG
- CSL Limited
- Fusion Health Care Pvt. Ltd
Competitive Landscape
Key players competing in the global animal blood plasma products and derivatives market are Kedrion Biopharma, Inc.; LFB S.A; Octapharma AG; Takeda; Sanofi; Grifols; Bayer AG; Biotest AG; CSL Limited; and Fusion Health Care Pvt. Ltd.
Prominent players in the market conduct R&D activities that have immense importance to develop an effective and specified drug. Various organizations and governments heftily invest in these activities to increase growth prospects. Many companies implement strategic collaborations and mergers to witness significant growth.
Table Of Content
1. Executive Summary2. Assumptions and Acronyms Used
3. Research Methodology
4. Animal Blood Plasma Products and Derivatives Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Animal Blood Plasma Products and Derivatives Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Animal Blood Plasma Products and Derivatives Market - Supply Chain
4.5. Global Animal Blood Plasma Products and Derivatives Market Forecast
4.5.1. Animal Blood Plasma Products and Derivatives Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Animal Blood Plasma Products and Derivatives Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Animal Blood Plasma Products and Derivatives Market Absolute $ Opportunity
5. Global Animal Blood Plasma Products and Derivatives Market Analysis and Forecast by Applications
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Applications
5.2.2. Y-o-Y Growth Projections by Applications
5.3. Animal Blood Plasma Products and Derivatives Market Size and Volume Forecast by Applications
5.3.1. Cosmetic
5.3.2. Diagnostic
5.3.3. Pet Food
5.3.4. Cell Culture Media
5.3.5. Food
5.3.6. Pharmaceutical
5.3.7. Sports Nutrition
5.3.8. Nutrition Supplements
5.4. Absolute $ Opportunity Assessment by Applications
5.5. Market Attractiveness/Growth Potential Analysis by Applications
6. Global Animal Blood Plasma Products and Derivatives Market Analysis and Forecast by Region
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Region
6.2.2. Y-o-Y Growth Projections by Region
6.3. Animal Blood Plasma Products and Derivatives Market Size and Volume Forecast by Region
6.3.1. North America
6.3.2. Latin America
6.3.3. Europe
6.3.4. Asia Pacific
6.3.5. Middle East and Africa (MEA)
6.4. Absolute $ Opportunity Assessment by Region
6.5. Market Attractiveness/Growth Potential Analysis by Region
6.6. Global Animal Blood Plasma Products and Derivatives Demand Share Forecast, 2019-2026
7. North America Animal Blood Plasma Products and Derivatives Market Analysis and Forecast
7.1. Introduction
7.1.1. Basis Point Share (BPS) Analysis by Country
7.1.2. Y-o-Y Growth Projections by Country
7.2. North America Animal Blood Plasma Products and Derivatives Market Size and Volume Forecast by Country
7.2.1. U.S.
7.2.2. Canada
7.3. Absolute $ Opportunity Assessment by Country
7.4. North America Animal Blood Plasma Products and Derivatives Market Size and Volume Forecast by Applications
7.4.1. Cosmetic
7.4.2. Diagnostic
7.4.3. Pet Food
7.4.4. Cell Culture Media
7.4.5. Food
7.4.6. Pharmaceutical
7.4.7. Sports Nutrition
7.4.8. Nutrition Supplements
7.5. Basis Point Share (BPS) Analysis by Applications
7.6. Y-o-Y Growth Projections by Applications
7.7. Market Attractiveness/Growth Potential Analysis
7.7.1. By Country
7.7.2. By Product Type
7.7.3. By Application
7.8. North America Animal Blood Plasma Products and Derivatives Demand Share Forecast, 2019-2026
8. Latin America Animal Blood Plasma Products and Derivatives Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.1.3. Latin America Average Pricing Analysis
8.2. Latin America Animal Blood Plasma Products and Derivatives Market Size and Volume Forecast by Country
8.2.1. Brazil
8.2.2. Mexico
8.2.3. Rest of Latin America
8.3. Absolute $ Opportunity Assessment by Country
8.4. Latin America Animal Blood Plasma Products and Derivatives Market Size and Volume Forecast by Applications
8.4.1. Cosmetic
8.4.2. Diagnostic
8.4.3. Pet Food
8.4.4. Cell Culture Media
8.4.5. Food
8.4.6. Pharmaceutical
8.4.7. Sports Nutrition
8.4.8. Nutrition Supplements
8.5. Basis Point Share (BPS) Analysis by Applications
8.6. Y-o-Y Growth Projections by Applications
8.7. Market Attractiveness/Growth Potential Analysis
8.7.1. By Country
8.7.2. By Product Type
8.7.3. By Application
8.8. Latin America Animal Blood Plasma Products and Derivatives Demand Share Forecast, 2019-2026
9. Europe Animal Blood Plasma Products and Derivatives Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Europe Average Pricing Analysis
9.2. Europe Animal Blood Plasma Products and Derivatives Market Size and Volume Forecast by Country
9.2.1. Germany
9.2.2. France
9.2.3. Italy
9.2.4. U.K.
9.2.5. Spain
9.2.6. Russia
9.2.7. Rest of Europe
9.3. Absolute $ Opportunity Assessment by Country
9.4. Europe Animal Blood Plasma Products and Derivatives Market Size and Volume Forecast by Applications
9.4.1. Cosmetic
9.4.2. Diagnostic
9.4.3. Pet Food
9.4.4. Cell Culture Media
9.4.5. Food
9.4.6. Pharmaceutical
9.4.7. Sports Nutrition
9.4.8. Nutrition Supplements
9.5. Basis Point Share (BPS) Analysis by Applications
9.6. Y-o-Y Growth Projections by Applications
9.7. Market Attractiveness/Growth Potential Analysis
9.7.1. By Country
9.7.2. By Product Type
9.7.3. By Application
9.8. Europe Animal Blood Plasma Products and Derivatives Demand Share Forecast, 2019-2026
10. Asia Pacific Animal Blood Plasma Products and Derivatives Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Asia Pacific Average Pricing Analysis
10.2. Asia Pacific Animal Blood Plasma Products and Derivatives Market Size and Volume Forecast by Country
10.2.1. China
10.2.2. Japan
10.2.3. South Korea
10.2.4. India
10.2.5. Australia
10.2.6. Rest of Asia Pacific (APAC)
10.3. Absolute $ Opportunity Assessment by Country
10.4. Asia Pacific Animal Blood Plasma Products and Derivatives Market Size and Volume Forecast by Applications
10.4.1. Cosmetic
10.4.2. Diagnostic
10.4.3. Pet Food
10.4.4. Cell Culture Media
10.4.5. Food
10.4.6. Pharmaceutical
10.4.7. Sports Nutrition
10.4.8. Nutrition Supplements
10.5. Basis Point Share (BPS) Analysis by Applications
10.6. Y-o-Y Growth Projections by Applications
10.7. Market Attractiveness/Growth Potential Analysis
10.7.1. By Country
10.7.2. By Product Type
10.7.3. By Application
10.8. Asia Pacific Animal Blood Plasma Products and Derivatives Demand Share Forecast, 2019-2026
11. Middle East & Africa Animal Blood Plasma Products and Derivatives Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Middle East & Africa Average Pricing Analysis
11.2. Middle East & Africa Animal Blood Plasma Products and Derivatives Market Size and Volume Forecast by Country
11.2.1. Saudi Arabia
11.2.2. South Africa
11.2.3. UAE
11.2.4. Rest of Middle East & Africa (MEA)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Middle East & Africa Animal Blood Plasma Products and Derivatives Market Size and Volume Forecast by Applications
11.4.1. Cosmetic
11.4.2. Diagnostic
11.4.3. Pet Food
11.4.4. Cell Culture Media
11.4.5. Food
11.4.6. Pharmaceutical
11.4.7. Sports Nutrition
11.4.8. Nutrition Supplements
11.5. Basis Point Share (BPS) Analysis by Applications
11.6. Y-o-Y Growth Projections by Applications
11.7. Market Attractiveness/Growth Potential Analysis
11.7.1. By Country
11.7.2. By Product Type
11.7.3. By Application
11.8. Middle East & Africa Animal Blood Plasma Products and Derivatives Demand Share Forecast, 2019-2026
12. Competition Landscape
12.1. Global Animal Blood Plasma Products and Derivatives Market: Market Share Analysis
12.2. Animal Blood Plasma Products and Derivatives Distributors and Customers
12.3. Animal Blood Plasma Products and Derivatives Market: Competitive Dashboard
12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
12.4.1. Kedrion Biopharma, Inc.
12.4.2. LFB S.A
12.4.3. Octapharma AG
12.4.4. Takeda
12.4.5. Sanofi
12.4.6. Grifols
12.4.7. Bayer AG
12.4.8. Biotest AG
12.4.9. CSL Limited
12.4.10. Fusion Health Care Pvt. Ltd
Methodology
Related Reports
Some other reports from this category!
Our Clients
